Type 1 Diabetes UK Immunotherapy Consortium
Finding new & better treatments for Type 1 Diabetes
Type 1 Diabetes UK Immunotherapy Consortium (T1D UK) was set up in 2015 with major funding from Diabetes UK & the JDRF, to promote, develop and support immunotherapy research in T1D.
23 Research Centres
We have a network of 23 Research Sites throughout the UK that will be conducting T1D Immunotherapy trials, with additional referrals to those sites from the ADDRESS-2 recruitment support network.
1
2
3
4
5
6
7
8
9
10
11
12
13
Our Partners
The consortium is funded by DUK and JDRF with a network of partners.
